Your browser doesn't support javascript.
loading
Feasibility assessment of measles and rubella eradication.
Moss, William J; Shendale, Stephanie; Lindstrand, Ann; O'Brien, Katherine L; Turner, Nikki; Goodman, Tracey; Kretsinger, Katrina.
Afiliação
  • Moss WJ; International Vaccine Access Center, Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: wmoss1@jhu.edu.
  • Shendale S; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Lindstrand A; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • O'Brien KL; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Turner N; Division of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
  • Goodman T; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Kretsinger K; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Vaccine ; 39(27): 3544-3559, 2021 06 16.
Article em En | MEDLINE | ID: mdl-34045102
ABSTRACT
This report addresses the epidemiological aspects and feasibility of measles and rubella eradication and the potential resource requirements in response to the request of the Director-General at the Seventieth World Health Assembly held on May 31, 2017. A guiding principle is that the path toward measles and rubella eradication should serve to strengthen primary health care, promote universal health coverage, and be a pathfinder for new vision and strategy for immunization over the next decade as laid out in the Immunization Agenda 2030. Specifically, this report 1) highlights the importance of measles and rubella as global health priorities; 2) reviews the current global measles and rubella situation; 3) summarizes prior assessments of the feasibility of measles and rubella eradication; 4) assesses the progress and challenges in achieving regional measles and rubella elimination; 5) assesses additional considerations for measles and rubella eradication, including the results of modelling and economic analyses; 6) assesses the implications of establishing a measles and rubella eradication goal and the process for setting an eradication target date; 7) proposes a framework for determining preconditions for setting a target date for measles and rubella eradication and how these preconditions should be understood and used; and 8) concludes with recommendations endorsed by SAGE.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Rubéola (Sarampo Alemão) / Sarampo Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Rubéola (Sarampo Alemão) / Sarampo Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article